产品介绍
Product Description
Biochem/physiol Actions
Tetrahydrozoline is an α-adrenergic agonist and an imidazoline derivative. It plays a crucial role in the constriction of conjunctival blood vessels. Tetrahydrozoline is a common component of nasal and eye drop formulations.
Features and Benefits
This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
技术参数
Specifications
| Quality Level | 200 |
| assay | ≥98% (HPLC) |
| solubility | H2O: freely soluble,alcohol: freely soluble,chloroform: very slightly soluble,diethyl ether: insoluble |
| originator | Novartis |
| SMILES string | Cl.C1CC(C2=NCCN2)c3ccccc3C1 |
| InChI | 1S/C13H16N2.ClH/c1-2-6-11-10(4-1)5-3-7-12(11)13-14-8-9-15-13;/h1-2,4,6,12H,3,5,7-9H2,(H,14,15);1H |
| InChI key | BJORNXNYWNIWEY-UHFFFAOYSA-N |
| Gene Information | human ... ADRA1A(148), ADRA1B(147), ADRA1D(146), ADRA2A(150), ADRA2B(151), ADRA2C(152) |
